Biotricity, Inc. Stock Other OTC
Equities
BTCY
US09074H1041
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 12M | Sales 2025 * | 14.3M | Capitalization | 11.84M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.99 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.83 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.74% |
Latest transcript on Biotricity, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Waqaas Al-Siddiq
CEO | Chief Executive Officer | 39 | 12-08-28 |
John Ayanoglou
DFI | Director of Finance/CFO | 57 | 17-10-26 |
Spencer LaDow
CTO | Chief Tech/Sci/R&D Officer | - | 16-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald McClurg
BRD | Director/Board Member | 65 | 22-05-03 |
Chet White
BRD | Director/Board Member | 59 | 22-08-10 |
David Rosa
BRD | Director/Board Member | 59 | 16-05-02 |
1st Jan change | Capi. | |
---|---|---|
-4.07% | 3.2B | |
-5.53% | 170M | |
-14.17% | 84.67M | |
+31.88% | 61.22M |